- Fee assured
- Verified account
Ms Morjaria is a multiple award-winning Consultant and Lead of the retinal genetics service at the Birmingham Midland Eye Centre, UK. She is extensively trained completing her medical degree and post graduate certificate in genetics with a distinction. Ms Morjaria completed her PhD and retinal fellowship at the John Radcliffe hospital, Oxford, which is world renowned for its advances in retinal gene therapy. Her PhD was with University College London.
Her areas of expertise are cataract surgery, retinal injection therapies, medical retina, macular degeneration, diabetic eye disease and cataract surgery.
As a retinal surgeon, she is referred complex retinal conditions including diabetes, macular degeneration, uveitis and retinal genetics.
She has published over 20 peer-reviewed research articles, lectured nationally and internationally and taught extensively in her field.
West Midlands Trainee Award Nominee.
Midland Ophthalmology Society Travel Award; Best oral presentation.
Midland Ophthalmology Society Travel Award; Best poster presentation.
Roper Hall Prize “Runner up”; Oral Presentation.
She provides treatments of cataracts, diabetic and age related retinal conditions, inherited rare conditions, inflammatory eye conditions and most other retinal conditions.
Areas of interest
Medical Retina; Cataracts; Intravitreal injections, General Ophthalmology; Diabetic Retinopathy; Macular Degeneration, Retinitis Pigmentosa; Uveitis; Retinal Laser;
Current NHS consultant posts held
Sandwell & West Birmingham NHS Hospital.
Birmingham & Midland Eye Centre.
The Impact of Sleep on Ocular Diseases
Retinitis Pigmentosa, Diabetic Retinopathy and Macular degeneration
Sourdough baking, Cycling, Swimming and Running
(Additional) Languages spoken
- Gujarati - Native or bilingual
- Hindi - Conversational
- French - Basic
- Panjabi, Punjabi - Basic
Eponymous syndromes. Oxford Handbook of Ophthalmology. 4th Edition.
Impact of Diabetic Retinopathy on Sleep and Mood. Invest Ophthalmol Vis Sci. 2019 Aug; 60(10):3421.
Treating diabetic macular oedema (DMO): real world UK clinical outcomes for the 0.19mg Fluocinolone Acetonide intravitreal implant (Iluvien™) at 2 years. BMC Ophthalmology. 2018 Feb;(18):63
A Dropped Lens. BMJ Minerva. 2017 Dec.
Comparing Micro-perimetric and Structural Findings in Patients with Branch Retinal Vein Occlusion and Diabetic Macular Edema. Retina. 2017 Nov;39(3):446-451.
Retained Contact Lenses. BMJ 2017.
Structural-functional correlation in patients with diabetic macular edema. Retina 2017 May;37(5):881-885.
Comparing macular thickness measurements in patients with diabetic macular edema with the Optos Spectral OCT/SLO and Heidelberg Spectralis HRA + OCT. Vision. 2017 Mar;1(1):2.
The impact of ocular deficits on sleep and mood: A case series study. Journal of Sleep Research. 2016 (25):199. Blackwell Publishing Ltd.
MIDME; Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema. Clinical Ophthalmology. Dec 2015: 11 (9); 2305-11.
An atypical presentation of patent foramen ovale. JRSMOpen. 2015 Aug;19(6).
Lowering the Limit: reducing the CD4 T cell threshold for
ophthalmic screening in patients with HIV in an ethnically-diverse UK Population. Clin Ophthalmol. Oct 2014:8;2029-34.
The impact of ocular deficits on sleep and mood: A case series study. Journal of Sleep Research. 2014 (23):126. Blackwell Publishing Ltd.
PK evaluation of pegatanib octasodium for the treatment of diabetic macula oedema. Expert Opin Drug Metab Toxicol. 2014 Aug;10(8):1185-92.
Peripheral ulcerative keratitis as a complication of acute myeloid leukaemia. BMJ Case reports. 2014 Oct.
Bilateral microbial keratitis in a case of severe xerophthalmia following small bowel resection. Journal of Royal Society of Medicine.2011; 104: 124-126
Courses offered to GPs
The Red Eye
Management of Retinal disease and risk factors in the community
Common Eye emergencies
Outcomes (checked and approved by medical professional body)
Please click on this link if you would like to see information about this healthcare professional’s performance compared to their peers, as published by their medical professional body.https://www.gmc-uk.org/doctors/6122403
I have a less than 1% complication rate.
I have had a 0% infection rate since September 2019, 0% mortality rate.
I have received several patient satisfaction letters.
- MBChB Birmingham University 2005
- FRCOphth Royal College of Ophthalmologists 2013
- PhD University College London 2018
Reference number 6122403
Professional bodies (positions held - last 3 yrs)
- General Medical Council GMC 2007
Details of entry to specialist register
- Royal College of Ophthalmologists, 2018
Affiliations / memberships
Midland Ophthalmological Society
UK Eye Genetics Group
General Medical Council
Royal College of Ophthalmologists
- 22 George RoadEdgbastonBirminghamB15 1PJ
- 08:30 - 17:00
- 0121 605 1884
- Little Aston Hall DriveLittle Aston SUTTON...
- 09:00 - 13:00
- 0121 605 1884
Post treatment communication
In the event of an urgent query following treatment, Bupa members should use the following contact details